Skip to content

ObetaCARE pilot

ObetaCARE pilot: OBEsity TAilered CArdiac REhabilitation - ObetaCARE pilot

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57869
Enrollment
25
Registered
2025-03-20
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome (ACS), Acute Myocardial Infarction, Unstable Angina Pectoris, Stable Angina Pectoris, Chronic Heart Failure, Congenital Heart Defect, Heart Transplantation, Atrial Fibrillation or Other Treated Arrhythmias, Atypical Thoracic Pain (Heart Anxiety)

Interventions

The ObetaCARE intervention is a newly developed specialized CR program for patients with obesity (BMI =30 kg/m²), incorporating a CAPRI GUIDE to support patients during the CR program and referring th

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: BMI =30 kg/m², age =18 years, diagnosed cardiovascular disease requiring CR, willing and able to provide informed consent

Exclusion criteria

Exclusion criteria: Contraindications for exercise-based cardiac rehabilitation, Severe cognitive impairment affecting adherence to the program, any condition that significantly limits participation in lifestyle interventions. 

Design outcomes

Primary

MeasureTime frame
Feasibility of the program, assessed through successful referral rates to structured follow-up care.

Secondary

MeasureTime frame
Key Health Outcomes (proof-of-concept), evaluation of the CAPRI Guide’s role in CR and post-rehabilitation support, factors influencing the ObetaCARE effectiveness and comparison of Key Health Outcomes Between ObetaCARE and the previously performed OPTICARE XL RCT (MEC-2016-622).

Countries

Netherlands

Contacts

Public ContactN Hoeve

Erasmus MC, Universitair Medisch Centrum Rotterdam

n.terhoeve@erasmusmc.nl0630000181

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)